ICM
MNRO icon

Invenomic Capital Management’s Monro MNRO Stock Holding History

Invenomic Capital Management’s Portfolio MNRO Stock Details MNRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-325,028
Closed -$6.51M – 168
2025
Q4 		$6.51M Sell
325,028
-209,150
-39% -$3.85M 0.3% 99
2025
Q3 		$9.6M Sell
534,178
-93,739
-15% -$1.54M 0.46% 72
2025
Q2 		$9.36M Buy
627,917
+17,133
+3% +$247K 0.53% 67
2025
Q1 		$8.84M Buy
610,784
+131,357
+27% +$2.51M 0.45% 80
2024
Q4 		$11.9M Buy
479,427
+33,450
+8% +$917K 0.57% 52
2024
Q3 		$12.9M Sell
445,977
-65,146
-13% -$1.68M 0.71% 48
2024
Q2 		$12.2M Buy
511,123
+373,255
+271% +$9.96M 0.59% 57
2024
Q1 		$4.35M Buy
+137,868
New +$4.26M 0.23% 100

Other funds holding MNRO

IC
Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Invenomic Capital Management's MNRO Position: Q1 2026 in Review

Invenomic Capital Management sold out of Monro (MNRO) in Q1 2026, closing a stake of 325,028 shares — an estimated $6.51M sold.

Invenomic Capital Management first reported a position in MNRO in Q1 2024 and held it in 8 quarters. The position peaked at $12.9M in Q3 2024. 184 funds tracked by Wall St. Rank hold MNRO as of Q1 2026.

  • Invenomic Capital Management reported no remaining Monro position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 325,028 Monro shares in Q1 2026, an estimated $6.51M.
  • Invenomic Capital Management first reported a position in Monro in Q1 2024 and held it in 8 quarters.
  • Invenomic Capital Management's Monro position peaked at $12.9M in Q3 2024.
  • 184 funds tracked by Wall St. Rank held Monro as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.